Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,899.60
(
0.11%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
93.67
(
-1.42%
)
Bitcoin
78,023.30
(
2.22%
)
News Focus
News Focus
Post# of 822358
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

meirluc

Send PM Follow Ignore
Followers 57
Posts 3147
Boards Moderated 0
Alias Born 02/01/2017

meirluc

Re: dennisdave post# 452369

Friday, 03/18/2022 12:21:02 PM

Friday, March 18, 2022 12:21:02 PM

Post# of 822358
dennisdave, please share with us what are the solid indications that lead you to believe that the journal publication has encountered some tough and difficult obstacles and that NWBO had therefore decided to postpone the publication and still go for RA approval.

Also what information do you have that NWBO had requested an MHRA approval and if the MHRA had dismissed the request, production of DCVax-L in the UK would have already been terminated?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News